Arthur Zaske & Associates’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
2017
Q3
$86K Sell
2017
Q2
$116K Buy
2017
Q1
$82K Buy